The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers.
SPDR® S&P Biotech ETF XBI
Morningstar’s Analysis XBI
Will XBI outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 16.0
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novavax Inc | 3.10 | 207.5 Mil | Healthcare |
Insmed Inc | 2.15 | 144.1 Mil | Healthcare |
Moderna Inc | 1.61 | 107.4 Mil | Healthcare |
Natera Inc | 1.38 | 92.3 Mil | Healthcare |
Revolution Medicines Inc Ordinary Shares | 1.31 | 87.5 Mil | Healthcare |
Dyne Therapeutics Inc Ordinary Shares | 1.31 | 87.4 Mil | Healthcare |
PTC Therapeutics Inc | 1.26 | 84.1 Mil | Healthcare |
United Therapeutics Corp | 1.23 | 82.4 Mil | Healthcare |
Blueprint Medicines Corp | 1.22 | 81.5 Mil | Healthcare |
Crinetics Pharmaceuticals Inc | 1.21 | 81.1 Mil | Healthcare |